Derek Raghavan, MD, PhD, FACP, FRACP is an internationally-renowned cancer researcher, medical oncologist and president of Atrium Health’s Levine Cancer Institute. Since joining the Institute in April 2011, Dr. Raghavan has pioneered an innovative approach to cancer care that eliminates the natural barriers to top-quality care, such as distance to clinical and research sites, culture, access, and more. Dr. Raghavan’s clinical and research interests are focused on genitourinary cancer, cancer in the elderly, anticancer drug discovery and development, and comparative human oncology. Dr. Raghavan currently serves on the editorial board for numerous medical journals; serves on the editorial board for HemOnc Today; has appeared in national media outlets such as Wall Street Journal, New York Times, NBC News, The Associated Press, 60 Minutes; been a principal investigator for more than a dozen major research grants; has published more than 300 papers in peer-reviewed professional journals; and edited nine textbooks. Additionally, he serves on the external advisory boards of cancer centers at Washington University, University of Miami, Roswell Park Cancer Institute and Virginia Commonwealth University.